Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Metz, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Metz, S. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 40, Issue 12 1565-1573, Copyright © 1991 by American Diabetes Association


ARTICLES

The pancreatic islet as Rubik's Cube. Is phospholipid hydrolysis a piece of the puzzle?

SA Metz
Department of Medicine, University of Wisconsin School of Medicine, Madison.

At least three types of phospholipase exist in the beta-cells of the pancreatic islet. Data regarding their physiological activation are incomplete but suggest that glucose (or its metabolite glyceraldehyde) either activates or potentiates the activation of several phospholipases. At least seven phospholipid hydrolysis by-products (diacylglycerol, myo-inositol 1,4,5-trisphosphate, lysophospholipids, arachidonic acid and its cyclooxygenase- and lipoxygenase-derived metabolites, phosphatidate) have been demonstrated to have effects compatible with their postulated roles as mediators or modulators of islet function. Presumptive mechanisms of action have been tentatively identified for these metabolites. However, key studies in the puzzle are missing, and current methodologies have important limitations. Shortcomings include the paucity of measurements of the mass of metabolites; the frequent use of static incubations rather than perfusions; a lack of complete time- and agonist concentration-dependence curves; the equation of metabolite accumulation with rates of metabolite generation (which ignores metabolite removal as a key variable); the use of nonspecific, insensitive, or ambiguous phospholipase assays; and the need for more studies directly correlating lipid metabolism and insulin secretion in physiologically functioning preparations. Like Rubik's Cube, the pancreatic islet is a dynamic puzzle comprised of many interrelated components requiring proper alignment and integration. Phospholipid turnover is one "panel" in the islet; however, an obligate role for phospholipase activation in glucose-induced insulin secretion is not yet rigorously established, despite tantalizing, inferential evidence. It may be that glucose serves principally to potentiate the phospholipase and secretory responses to other signals that act by initiating phospholipid hydrolysis.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
P. McDonald, R. Veluthakal, H. Kaur, and A. Kowluru
Biologically active lipids promote trafficking and membrane association of Rac1 in insulin-secreting INS 832/13 cells
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1216 - C1220.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Kowluru and R. Veluthakal
Rho Guanosine Diphosphate-Dissociation Inhibitor Plays a Negative Modulatory Role in Glucose-Stimulated Insulin Secretion
Diabetes, December 1, 2005; 54(12): 3523 - 3529.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. Gilon and J.-C. Henquin
Mechanisms and Physiological Significance of the Cholinergic Control of Pancreatic {beta}-Cell Function
Endocr. Rev., October 1, 2001; 22(5): 565 - 604.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Salehi, B.-G. Fan, M. Ekelund, G. Nordin, and I. Lundquist
TPN-evoked dysfunction of islet lysosomal activity mediates impairment of glucose-stimulated insulin release
Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E171 - E179.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1991 by the American Diabetes Association.